He Wang, Kai Wang, Yutian Wang, Zhenlei Liu, Lei Zhang, Shanhang Jia, Kun He, Xiangyu Zhang, Hao Wu
{"title":"基于mri的机器学习和放射组学方法评估轻度脊髓型颈椎病患者脊髓功能。","authors":"He Wang, Kai Wang, Yutian Wang, Zhenlei Liu, Lei Zhang, Shanhang Jia, Kun He, Xiangyu Zhang, Hao Wu","doi":"10.3390/bioengineering12060666","DOIUrl":null,"url":null,"abstract":"<p><p>(1) Background: Patients with mild cervical spondylotic myelopathy (CSM) who delay surgery risk progression. While PET evaluates spinal cord function, its cost and radiation limit its use. (2) Methods: In this prospective study, patients with mild cervical spondylosis underwent preoperative 18F-FDG PET-MRI. Narrowed spinal levels were classified based on whether SUV<sub>max</sub> was decreased. Follow-up assessments were conducted. Two machine learning models using MRI T2-based radiomics were developed to identify stenotic levels and decreased SUV<sub>max</sub>. (3) Results: Patients with normal SUV<sub>max</sub> showed greater symptom improvement. The radiomics models performed well, with AUCs of 0.981/0.962 (training/testing) for stenosis detection and 0.830/0.812 for predicting SUV<sub>max</sub> decline. The model outperformed clinicians in predicting SUV<sub>max</sub> decline, improving the AUC by 10%. (4) Conclusion: Patients with preserved SUV<sub>max</sub> have better outcomes. MRI-based radiomics shows potential for identifying stenosis and predicting spinal cord function changes for preoperative assessment, though larger studies are needed to validate its clinical utility.</p>","PeriodicalId":8874,"journal":{"name":"Bioengineering","volume":"12 6","pages":""},"PeriodicalIF":3.8000,"publicationDate":"2025-06-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12189521/pdf/","citationCount":"0","resultStr":"{\"title\":\"MRI-Based Machine Learning and Radiomics Methods for Assessing Spinal Cord Function in Patients with Mild Cervical Spondylotic Myelopathy.\",\"authors\":\"He Wang, Kai Wang, Yutian Wang, Zhenlei Liu, Lei Zhang, Shanhang Jia, Kun He, Xiangyu Zhang, Hao Wu\",\"doi\":\"10.3390/bioengineering12060666\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>(1) Background: Patients with mild cervical spondylotic myelopathy (CSM) who delay surgery risk progression. While PET evaluates spinal cord function, its cost and radiation limit its use. (2) Methods: In this prospective study, patients with mild cervical spondylosis underwent preoperative 18F-FDG PET-MRI. Narrowed spinal levels were classified based on whether SUV<sub>max</sub> was decreased. Follow-up assessments were conducted. Two machine learning models using MRI T2-based radiomics were developed to identify stenotic levels and decreased SUV<sub>max</sub>. (3) Results: Patients with normal SUV<sub>max</sub> showed greater symptom improvement. The radiomics models performed well, with AUCs of 0.981/0.962 (training/testing) for stenosis detection and 0.830/0.812 for predicting SUV<sub>max</sub> decline. The model outperformed clinicians in predicting SUV<sub>max</sub> decline, improving the AUC by 10%. (4) Conclusion: Patients with preserved SUV<sub>max</sub> have better outcomes. MRI-based radiomics shows potential for identifying stenosis and predicting spinal cord function changes for preoperative assessment, though larger studies are needed to validate its clinical utility.</p>\",\"PeriodicalId\":8874,\"journal\":{\"name\":\"Bioengineering\",\"volume\":\"12 6\",\"pages\":\"\"},\"PeriodicalIF\":3.8000,\"publicationDate\":\"2025-06-17\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12189521/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Bioengineering\",\"FirstCategoryId\":\"5\",\"ListUrlMain\":\"https://doi.org/10.3390/bioengineering12060666\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"ENGINEERING, BIOMEDICAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bioengineering","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.3390/bioengineering12060666","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ENGINEERING, BIOMEDICAL","Score":null,"Total":0}
MRI-Based Machine Learning and Radiomics Methods for Assessing Spinal Cord Function in Patients with Mild Cervical Spondylotic Myelopathy.
(1) Background: Patients with mild cervical spondylotic myelopathy (CSM) who delay surgery risk progression. While PET evaluates spinal cord function, its cost and radiation limit its use. (2) Methods: In this prospective study, patients with mild cervical spondylosis underwent preoperative 18F-FDG PET-MRI. Narrowed spinal levels were classified based on whether SUVmax was decreased. Follow-up assessments were conducted. Two machine learning models using MRI T2-based radiomics were developed to identify stenotic levels and decreased SUVmax. (3) Results: Patients with normal SUVmax showed greater symptom improvement. The radiomics models performed well, with AUCs of 0.981/0.962 (training/testing) for stenosis detection and 0.830/0.812 for predicting SUVmax decline. The model outperformed clinicians in predicting SUVmax decline, improving the AUC by 10%. (4) Conclusion: Patients with preserved SUVmax have better outcomes. MRI-based radiomics shows potential for identifying stenosis and predicting spinal cord function changes for preoperative assessment, though larger studies are needed to validate its clinical utility.
期刊介绍:
Aims
Bioengineering (ISSN 2306-5354) provides an advanced forum for the science and technology of bioengineering. It publishes original research papers, comprehensive reviews, communications and case reports. Our aim is to encourage scientists to publish their experimental and theoretical results in as much detail as possible. All aspects of bioengineering are welcomed from theoretical concepts to education and applications. There is no restriction on the length of the papers. The full experimental details must be provided so that the results can be reproduced. There are, in addition, four key features of this Journal:
● We are introducing a new concept in scientific and technical publications “The Translational Case Report in Bioengineering”. It is a descriptive explanatory analysis of a transformative or translational event. Understanding that the goal of bioengineering scholarship is to advance towards a transformative or clinical solution to an identified transformative/clinical need, the translational case report is used to explore causation in order to find underlying principles that may guide other similar transformative/translational undertakings.
● Manuscripts regarding research proposals and research ideas will be particularly welcomed.
● Electronic files and software regarding the full details of the calculation and experimental procedure, if unable to be published in a normal way, can be deposited as supplementary material.
● We also accept manuscripts communicating to a broader audience with regard to research projects financed with public funds.
Scope
● Bionics and biological cybernetics: implantology; bio–abio interfaces
● Bioelectronics: wearable electronics; implantable electronics; “more than Moore” electronics; bioelectronics devices
● Bioprocess and biosystems engineering and applications: bioprocess design; biocatalysis; bioseparation and bioreactors; bioinformatics; bioenergy; etc.
● Biomolecular, cellular and tissue engineering and applications: tissue engineering; chromosome engineering; embryo engineering; cellular, molecular and synthetic biology; metabolic engineering; bio-nanotechnology; micro/nano technologies; genetic engineering; transgenic technology
● Biomedical engineering and applications: biomechatronics; biomedical electronics; biomechanics; biomaterials; biomimetics; biomedical diagnostics; biomedical therapy; biomedical devices; sensors and circuits; biomedical imaging and medical information systems; implants and regenerative medicine; neurotechnology; clinical engineering; rehabilitation engineering
● Biochemical engineering and applications: metabolic pathway engineering; modeling and simulation
● Translational bioengineering